Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.

Targeting tumour microenvironment by tyrosine kinase inhibitor

Open access

Abstract

Tumour microenvironment (TME) is a key determinant of tumour growth and metastasis. TME could be very different for each type and location of tumour and TME may change constantly during tumour growth. Multiple counterparts in surrounding microenvironment including mesenchymal-, hematopoietic-originated cells as well as non-cellular components affect TME. Thus, therapeutics that can disrupt the tumour-favouring microenvironment should be further explored for cancer therapy. Previous efforts in unravelling the dysregulated mechanisms of TME components has identified numerous protein tyrosine kinases, while its corresponding inhibitors have demonstrated potent modulatory effect on TME. Recent works have demonstrated that beyond the direct action on cancer cells, tyrosine kinase inhibitors (TKIs) have been implicated in inactivation or normalization of dysregulated TME components leading to cancer regression. Either through re-sensitizing the tumour cells or reversing the immunological tolerance microenvironment, the emergence of these TME modulatory mechanism of TKIs supports the combinatory use of TKIs with current chemotherapy or immunotherapy for cancer therapy. Therefore, an appropriate understanding on TME modulation by TKIs may offer another mode of action of TKIs for cancer treatment. This review highlights mode of kinase activation or paracrine ligand production from TME components and summarises the findings on the potential use of various TKIs on regulating TME components. At last, the combination use of current TKIs with immunotherapy in the perspectives of efficacy and safety are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-018-0800-6

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The implication of TKIs on mesenchymal-originated cells
Fig. 1 The implication of TKIs on mesenchymal-originated cellsCC BY · PubMed Central
Fig. 2 The immuno-regulatory effect of TKIs on suppressive populations in tumour microenvironment
Fig. 2 The immuno-regulatory effect of TKIs on suppressive populations in tumour microenvironmentCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 167 references

Cited by

See all 107

Metadata

Authors
Tan, H.-Y., Wang, N., Lam, W., Guo, W., Feng, Y., & Cheng, Y.-C.
Affiliations
  • University of Hong Kong (HK)
  • Yale University (US)
Corresponding author
  • Feng, Yibin
  • Cheng, Yung-Chi
Venue
Molecular Cancer
Published
2018-02-19
Volume
17
Issue
1
Pages
43-43
ISSN
1476-4598 (ISSN-L)
OpenAlex
W2794836336
Cited by
107
References
167
Citations by year
2026: 4 · 2025: 8 · 2024: 16 · 2023: 14 · 2022: 8 · 2021: 26 · 2020: 19 · 2019: 9 · 2018: 3
FWCI
1.49
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • research council of the University of Hong Kong (104003422, 104004092)
  • the Research Grants Committee (RGC) of Hong Kong (106160190)
  • Wong’s Donation on Modern Oncology of Chinese Medicine (200006276)
  • Gala Family Trust (200007008)
  • Government-Matching Grant Scheme (207060411)
  • HKU Overseas Fellowship Awards (102009600)
  • National Cancer Institute (PO1CA154295-01A1)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
tumor microenvironment, tyrosine kinase inhibitors, tyrosine kinase, tumor immunosuppression, combination immunotherapy, paracrine signaling, cancer therapy
MeSH terms
Animals, Humans, Immunotherapy, Neoplasms, Protein Kinase Inhibitors, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting tumour microenvironment by tyrosine kinase inhibitor. https://app.cochat.ai/papers/10.1186/s12943-018-0800-6
The paper
Tan, H.-Y., Wang, N., Lam, W., Guo, W., Feng, Y., & Cheng, Y.-C. (2018). Targeting tumour microenvironment by tyrosine kinase inhibitor. Molecular Cancer. https://doi.org/10.1186/s12943-018-0800-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.